Connaughton et al. [57] showed that the intermediate monocyte phenotype is also characterized by reduced CCR2 receptor expression, making it conceivable that intermediate monocytes in CLL patients with low CCR2-dependent increased miR-150-5p expression, but such a hypothesis requires further extensive studies. The gene discussed is CCR2; the disease is B-cell chronic lymphocytic leukemia.